Evaluating a Novel Immunotherapy in Dogs with Osteosarcoma
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Advancing Knowledge of the Molecular Mechanisms of Mast Cell Tumors
This fellowship investigates genetic lesions in canine mast cell tumors using cytogenetic and expression analysis.
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Working Toward an Immunotherapy for Osteosarcoma
Curbing Tumor Growth and Chemotherapy Resistance in Canine Hemangiosarcoma
Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.
Finding New Therapy Targets for Mast Cell Tumors
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.